Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.100
-0.200-1.77%
Volume:7.70M
Turnover:85.51M
Market Cap:28.50B
PE:17.62
High:11.350
Open:11.310
Low:11.020
Close:11.300
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:1.46
T/O Rate:0.30%
Dividend:0.21
Dividend Rate:1.86%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.59
PE(LYR):17.62
PS:2.80

Loading ...

Simcere Pharmaceutical Group (SEHK:2096) Stock Could Be 70% Below Fair Value After Stanford IPF Deal

Simply Wall St.
·
Jun 21

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Jun 15

Simcere Pharmaceutical Group Limited (HKG:2096) Passed Our Checks, And It's About To Pay A CN¥0.18 Dividend

Simply Wall St.
·
Jun 13

TransThera Sciences names Sun Delong chief operating officer

Reuters
·
Jun 12

SIMCERE PHARMA to Distribute Final Dividend of RMB 0.18 per Share on July 13

Stock News
·
Jun 12

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Stock News
·
Jun 12

BRIEF-Simcere Pharmaceutical Receives Clinical Trial Approval For SIM0689 From China's NMPA

Reuters
·
Jun 12

Simcere Pharmaceutical - Receives Clinical Trial Approval for Sim0689 From National Medical Products Administration

THOMSON REUTERS
·
Jun 12

Simcere Pharmaceutical declares final dividend of RMB 0.18 per share for FY2025

Reuters
·
Jun 12

Simcere Pharmaceutical shareholders approve new articles of association, bylaw amendments

Reuters
·
Jun 12

Simcere Pharmaceutical partners with Stanford Medicine on idiopathic pulmonary fibrosis therapy research

Reuters
·
Jun 12

Simcere Pharmaceutical Enters Into a Research Collaboration Agreement With Stanford Medicine to Develop Innovative Therapies for Patients With Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jun 12

SIMCERE PHARMA Shares Surge Over 3% Following Exclusive Distribution Deal for Novel Topical Treatment

Stock News
·
Jun 10

Simcere Pharma cancels 27.50 million shares, cutting outstanding stock by 1.06%

Bulletin Express
·
Jun 08

SIMCERE PHARMA Cancels Nearly 27.5 Million Repurchased Shares

Stock News
·
Jun 08

Simcere Pharmaceutical files HKEX next-day disclosure, reports share buyback at HKD 11.42/share

Reuters
·
Jun 08

Simcere Pharma Reports Stable Share Base in May 2026; Public Float Remains Above 15.45% Threshold

Bulletin Express
·
Jun 03

Simcere Pharma Wins Promotion Rights for PrimeGenX's Atopic Dermatitis Drug

MT Newswires Live
·
Jun 02

BRIEF-Simcere Pharmaceutical Enters Exclusive Promotion Service Agreement With Primegenx Therapeutics

Reuters
·
Jun 01

Simcere Pharma, PrimeGenX Ink Exclusive Promotion Deal for Pumecitinib Gel in Greater China

Bulletin Express
·
Jun 01